L233-0075 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-methyl-5-(3-phenyl-1,2,4-oxadiazol-5-yl)thiophene-3-sulfonamide

L233-0075 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-methyl-5-(3-phenyl-1,2,4-oxadiazol-5-yl)thiophene-3-sulfonamide
L233-0075 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-methyl-5-(3-phenyl-1,2,4-oxadiazol-5-yl)thiophene-3-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L233-0075
N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-methyl-5-(3-phenyl-1,2,4-oxadiazol-5-yl)thiophene-3-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L233-0075

Molecular Formula

C21H17N3O5S2 (C21 H17 N3 O5 S2)

Compound Name

N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-methyl-5-(3-phenyl-1,2,4-oxadiazol-5-yl)thiophene-3-sulfonamide

IUPAC name

N-[(2H-13-benzodioxol-5-yl)methyl]-2-methyl-5-(3-phenyl-124-oxadiazol-5-yl)thiophene-3-sulfonamide

SMILES

Cc(sc(-c1nc(-c2ccccc2)no1)c1)c1S(NCc(cc1)cc2c1OCO2)(=O)=O

InChI

InChI=1S/C21H17N3O5S2/c1-13-19(31(25,26)22-11-14-7-8-16-17(9-14)28-12-27-16)10-18(30-13)21-23-20(24-29-21)15-5-3-2-4-6-15/h2-10,22H,11-12H2,1H3

InChI Key

ZVKFVSWLSCZXGR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27237157

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

455.52

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.962

Distribution Coefficient, logD

4.961

Water Solubility, LogSw

-4.70

Polar Surface Area

91.536

Acid Dissociation Constant (pKa)

10.36

Base Dissociation Constant (pKb)

-4.89

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

14.30

L233-0075 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L233-0075 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L233-0075?
Check Price and Availability of L233-0075, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L233-0075 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L233-0075
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L233-0075
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L233-0075 available by request